Evolent Health, Inc. (EVH)

Market Cap	468.72M
Revenue (ttm)	2.05B
Net Income (ttm)	-180.89M
Shares Out	111.60M
EPS (ttm)	-1.57
PE Ratio	n/a
Forward PE	17.72
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,953,330
Open	4.360
Previous Close	4.310
Day's Range	4.175 - 4.401
52-Week Range	3.495 - 13.615
Beta	0.24
Analysts	Strong Buy
Price Target	12.25 (+191.67%)
Earnings Date	Nov 6, 2025

About EVH

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workf...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jun 5, 2015
• Employees: 4,500
• Stock Exchange: NYSE
• Ticker Symbol: EVH
• Website: https://www.evolent.com

Financial Performance

In 2024, Evolent Health's revenue was $2.55 billion, an increase of 30.09% compared to the previous year's $1.96 billion. Losses were -$93.45 million, -34.31% less than in 2023.

Analyst Summary

According to 14 analysts, the average rating for EVH stock is "Strong Buy." The 12-month stock price target is $12.25, which is an increase of 191.67% from the latest price.

Price Target

$12.25

(191.67% upside)

Analyst Consensus: Strong Buy